SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Healthcare >

TransEnterix Inc. (TRXC)

TRXC RSS Feed
Add TRXC Price Alert      Hide Sticky   Hide Intro
Moderator: beambe, XJINVESTOR, SPORT19, n3m3sis
Search This Board: 
Last Post: 11/17/2017 6:20:55 PM - Followers: 145 - Board type: Free - Posts Today: 28

http://www.transenterix.com/


TransEnterix, Inc. operates as a development stage medical device company. The company is focused on the development and commercialization of SurgiBot™, a novel patient side minimally invasive surgical robotic system. It uses flexible instruments and robotics to improve the outcomes of minimally invasive surgery. The company was formerly known as SafeStitch Medical, Inc. after merger it has changed its name to TransEnterix, Inc. TransEnterix was founded in August 1988 and is headquartered in Morrisville, NC.

TRXC has finalized its design for the SurgiBot and will submit the device for FDA(510)k clearance in Q4 of 2014, expecting approval and commercialization in mid 2015.

The SurgiBot will retail for $500,000, and will be the first surgical robot on the market to compete with Intuitive Surgical's Da Vinci System for a fraction of the price. 

The SurgiBot has 100% tactile feedback, a huge feature that all surgeons look for when conducting surgery. TransEnterix's competitors, like TITXF, who is still far behind in the development of their SPORT system when compared to TransEnterix, has zero tactile and zero haptic feedback.

TRXC has 6 professional analysts covering the stock, all with buy ratings, and price targets as low as $6.00 per share, and as high as $10.00 per share. 

Oct 13 (Reuters) - U.S. FDA -

* FDA clears Senhance System, Transenterix Inc's new robotically-assisted surgical device for adult patients ‍? Source: (http://bit.ly/2wUfB9N) Further company coverage:

Events:
 

European Society of Gynaecological Oncology
Vienna, Austria
4 Nov - 7 Nov

TransEnterix Schedules Third Quarter 2017 Financial and Operating Results Conference Call for November 9, 2017

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to release third quarter 2017 financial and operating results after the market closes on Thursday, November 9, 2017. Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these results starting at 4:30 pm Eastern Time the same day. The call will be concurrently webcast.

To listen to the conference call on your telephone, please dial (844) 804-5261 for domestic callers and (612) 979-9885 for international callers, and reference conference ID 8898746 approximately ten minutes prior to the start time. To access the live audio webcast or archived recording, use the following link http://ir.transenterix.com/events.cfm. The replay will be available on the Company's website.

 

AAGL Global Congress 2017
National Harbor, MD
12 Nov - 16 Nov
National Harbor, Maryland USA

TransEnterix to Present at the Stifel 2017 Healthcare Conference

TransEnterix, Inc. (NYSE MKT:TRXC) announced today (31/10/2017) that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Stifel 2017 Healthcare Conference at The Lotte New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 5:00 PM Eastern Time on Tuesday, November 14, 2017.


 
SureTrader
Interactive Brokers Advertisement
TRXC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#3774  Sticky Note Any time you post about Users or reference n3m3sis 11/10/17 03:38:09 PM
#3528  Sticky Note Great information on this blog. Make sure you XJINVESTOR 11/04/17 05:30:56 PM
#3980   In at .52 I never got in on Belus 11/17/17 06:20:55 PM
#3979   Agreed brother! We ain’t pumping, just BULLISH!!! JohnnyMoneymaker 11/17/17 03:19:59 PM
#3978   So, you had this stock before this board Railrazor63 11/17/17 03:19:45 PM
#3977   Rail, Most people on here are not pumping Belus 11/17/17 02:58:53 PM
#3976   We may be down for the last 2 Belus 11/17/17 02:35:48 PM
#3975   Thanks for sharing. Looks like a pretty Longmoney 11/17/17 12:14:49 PM
#3974   Spanish news telemundo highlights Senhance. sleuth100 11/17/17 11:07:56 AM
#3973   You know, most everyone posting on here are Railrazor63 11/17/17 10:04:39 AM
#3972   Thank you for the crash course in capitalism Longmoney 11/17/17 09:55:58 AM
#3970   LOL not_again 11/17/17 08:26:08 AM
#3969   It's called Distraction...keep you hyped up with bogus not_again 11/17/17 08:10:03 AM
#3968   TRXC: Overwhelming demand for Senhance after FDA approval Dr_Biotechguru5 11/17/17 08:06:07 AM
#3967   The stock is down because of INSIDERS DUMPING!! not_again 11/17/17 08:01:33 AM
#3966   Multiple Senhance orders coming from US and EU Dr_Biotechguru5 11/17/17 07:50:52 AM
#3965   TRXC shares trading like classic hostile take over Dr_Biotechguru5 11/17/17 07:43:55 AM
#3964   By the way, how many of these halts jainash25 11/17/17 07:30:25 AM
#3963   Trading halt coming followed by Buy out PR Dr_Biotechguru5 11/17/17 07:25:05 AM
#3962   White research statement after SEC inquiry: We're going Dr_Biotechguru5 11/17/17 07:21:39 AM
#3961   SEC is investigating white research after complaint by Dr_Biotechguru5 11/17/17 07:16:22 AM
#3960   Please don't , really don't compare this tiny not_again 11/17/17 07:06:25 AM
#3959   LOL not_again 11/17/17 07:01:46 AM
#3958   You guys smell something? I smell pungent nasty Dr_Biotechguru5 11/17/17 06:57:07 AM
#3957   Here it is..... n3m3sis 11/17/17 05:03:37 AM
#3956   Simply put, the individual(s) is/are vested and therefore H2004 11/17/17 02:37:26 AM
#3955   Shorts sleep well tonight, very soon your brokerage Dr_Biotechguru5 11/17/17 01:46:53 AM
#3954   why in the world would an insider dump Longmoney 11/17/17 01:00:01 AM
#3953   My 2015 big hit Ocata Therapeutics CSO Dr. Dr_Biotechguru5 11/17/17 12:39:20 AM
#3952   It just hit me, that was a joke, H2004 11/16/17 11:29:36 PM
#3951   Wait for what? Joseph P. Slattery did wait. H2004 11/16/17 11:27:47 PM
#3950   There are no articles bashing TRXC from Seeking H2004 11/16/17 11:06:12 PM
#3949   "weak hands"?? you mean Joseph Slattery? an insider? not_again 11/16/17 09:43:15 PM
#3948   You would think that insiders would wait until not_again 11/16/17 09:31:52 PM
#3947   Wait wait weren’t these pre determined sale dates Adrock 11/16/17 09:30:13 PM
#3946   Please stop...HERE IS THE REASON THE PPS IS SINKING not_again 11/16/17 09:28:52 PM
#3945   More Insiders selling.....Responses.... not_again 11/16/17 09:26:03 PM
#3944   PPS being artificially low by SA bash Dr_Biotechguru5 11/16/17 06:34:42 PM
#3943   Garbage SA articles and weak hands that sell Dr_Biotechguru5 11/16/17 06:32:33 PM
#3942   I’m a holder of this trxc stocks for Hafonso76 11/16/17 04:26:24 PM
#3941   Maybe I should start shopping a beach front JohnnyMoneymaker 11/16/17 04:20:23 PM
#3939   oh okay, you were just saying "1 sale not_again 11/16/17 01:32:07 PM
#3938   100% TRXC will not be a stand alone Dr_Biotechguru5 11/16/17 01:18:41 PM
#3937   1 US sale Done...7 orders from last 2 Dr_Biotechguru5 11/16/17 01:01:29 PM
#3936   Hey guys, don't we have 1 US sale? BUT..... not_again 11/16/17 12:51:58 PM
#3935   I thought you were gone until your sell Railrazor63 11/16/17 12:37:22 PM
#3934   tomorrow, well this is about your fifth tomorrow. 2014trader 11/16/17 12:12:32 PM
#3933   Wait, what happened to the outright buyout last Longmoney 11/16/17 12:08:00 PM
#3932   Awesome whose your contact? Adrock 11/16/17 12:03:46 PM
#3931   TRXC: Major Partnership deal coming with big Japanese Dr_Biotechguru5 11/16/17 12:02:24 PM
#3930   TRXC: Major Positive Binary news tomorrow AM...TRXC stock Dr_Biotechguru5 11/16/17 12:00:20 PM
#3929   Yes, Nailed it, Belus 11/15/17 08:37:38 PM
PostSubject